COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018

被引：0
|
作者：
Costa, L. [1 ]
Hincapie, A. [1 ]
Guo, J. J. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.684
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG5
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [1] SAFETY EVALUATION OF ZOLEDRONIC ACID AND DENOSUMAB USING FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE 2012-2018
    Elsisi, Z.
    Lin, A. C.
    Guo, J.
    VALUE IN HEALTH, 2019, 22 : S169 - S169
  • [2] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [3] Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database
    Deng, Bin
    Li, Shijun
    You, Ruxu
    Fu, Zhiwen
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [4] Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
    Sonawane, Kalyani B.
    Cheng, Ning
    Hansen, Richard A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 682 - 690
  • [5] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [6] DESCRIPTIVE ANALYSIS OF ADVERSE EVENTS REPORTED ASSOCIATED WITH THE USE OF TIGECYCLINE OR MINOCYCLINE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE FROM 2008 TO 2021
    Almadfaa, R.
    Hincapie, A. L.
    Guo, J. J.
    VALUE IN HEALTH, 2022, 25 (07) : S446 - S447
  • [7] Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
    Iarikov D.
    Wassel R.
    Farley J.
    Nambiar S.
    Infectious Diseases and Therapy, 2015, 4 (4) : 433 - 458
  • [8] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [9] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [10] Examining the Nocebo Effect of Statins Using Statin Adverse Events Reported in the FDA Adverse Event Reporting System
    Moon, Jungyeon
    Sedgh, Robert Cohen
    Jackevicius, Cynthia
    CIRCULATION, 2020, 142
12345